|
General Thoracic-Miscellaneous
|
|
|
The Food and Drug Administration has approved a new agent for the urgent reversal of vitamin K antagonist anticoagulation in adults with acute major bleeding. Kcentra (Prothrombin Complex Concentrate, Human), manufactured by CSL Behring of King of Prussia, Pa., is a nonactivated 4-factor... »
Apps proliferate amid concerns about medical use
DENVER – Do you need a stethoscope, a blood pressure monitor, or a tool to assess cardiac rhythms? There are apps for that. In fact, by recent count there are more than 200,000 applications of technology – or "apps" – available for smartphones or tablet devices, and they’re being used... » Advances in technology from new forms of operative procedures, medical treatment, and imaging to electronic health record systems are rapidly changing thoracic surgery practice and cost structure. In addition, new government and insurance initiatives are changing the playing field at the same time... » The 2008 Medicare policy to withhold payment for treating certain hospital-acquired infections failed to decrease infection rates in U.S. hospitals, according to a report published online in the New England Journal of Medicine.
In a study involving a total of 398 hospitals or medical systems... » SAN FRANCISCO – Successful outcomes in 74 of 79 patients who underwent robotic-assisted thymectomy suggest that the technology is safe and feasible, results of a multicenter European study demonstrate.
Dr. Franca Melfi, of the University of Pisa in Italy, reported on 79 patients with early... »
New AATS Leadership Course Fills an Emerging Need
Nonpayment Fails to Help Infection Rates
New Data Back Safety of Robotic-Assisted Thymectomy
| Jun 26 - 29 Coeur d'Alene, ID | Western Thoracic Surgical Association (WTSA): Annual Meeting |
| Jun 27 - 29 Frankfurt, | Congenital and Structural Interventions (CSI 2013) |
| Oct 31 - Nov 2 Chicago, IL | American Society for Radiation Oncology (ASTRO): Chicago Multidisciplinary Symposium in Thoracic Oncology |